SB 665-FN (2026): relative to pharmacy benefits managers, managed care laws, notice of drug pricing options and pharmacy benefit manager business practices.

Cite this page

Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.

MLA
“SB 665-FN (2026): relative to pharmacy benefits managers, managed care laws, notice of drug pricing options and pharmacy benefit manager business practices.” Granite Record, https://graniterecord.org/bill/2026/sb665. Accessed 19 Oct. 2026.
APA
Granite Record. (n.d.). SB 665-FN (2026): relative to pharmacy benefits managers, managed care laws, notice of drug pricing options and pharmacy benefit manager business practices. Retrieved 19 Oct. 2026, from https://graniterecord.org/bill/2026/sb665
Chicago
Granite Record. “SB 665-FN (2026): relative to pharmacy benefits managers, managed care laws, notice of drug pricing options and pharmacy benefit manager business practices.” Accessed 19 Oct. 2026. https://graniterecord.org/bill/2026/sb665.
BibTeX
@misc{bill-2026-sb665, title = {SB 665-FN (2026): relative to pharmacy benefits managers, managed care laws, notice of drug pricing options and pharmacy benefit manager business practices.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2026/sb665}, note = {Accessed 19 Oct. 2026} }

SB 665-FN (2026)

relative to pharmacy benefits managers, managed care laws, notice of drug pricing options and pharmacy benefit manager business practices.

  • Status: Killed
  • Term: 2025-2026
  • House committee: Commerce and Consumer Affairs
  • Senate committee: Health and Human Services
  • Subject: Insurance

The Story

It was introduced on January 29, 2026 and referred to the Senate Health and Human Services committee. The committee held a public hearing on February 18, 2026. The committee voted unanimously, 5–0, to recommend that the Senate pass it with changes (amendment 2026-1047s), and the report was placed on the consent calendar. The bill was taken off the consent calendar on March 12, 2026. On March 12, 2026 the Senate adopted “Special Order to 03/26/2026, Without Objection”. The committee voted unanimously, 5–0, to recommend that the Senate pass it with changes (amendment 2026-1047s). The committee's amendment (2026-1047s) was adopted on a voice vote on March 26, 2026, changing the text of the bill. A floor amendment (2026-1239s), offered by Sen. Denise Ricciardi, was adopted on a voice vote on March 26, 2026, changing the text of the bill. A floor amendment (2026-1129s), offered by Sen. Cindy Rosenwald, was adopted on a voice vote on March 26, 2026, changing the text of the bill. On March 26, 2026 the Senate voted to pass it with changes and ordered it to a third reading. It crossed to the House on March 26, 2026 and was referred to the House Commerce and Consumer Affairs committee. The committee held a public hearing on April 15, 2026, with 10 people signed in online: 7 in support and 3 in opposition. The committee held work sessions on April 22, 2026 and April 28, 2026. The committee met in executive session on April 29, 2026 to vote on its recommendation. The majority recommended that the House kill it, and the minority recommended that the House pass it with changes (amendment 2026-1758h), by a vote of 13–2. The report was placed on the regular calendar. On May 14, 2026 the House voted to kill it on a voice vote.

Sponsors

Hearings and Sessions

  • February 18, 2026, 9:45 AM: hearing, Senate Health and Human Services, SH 100
  • March 12, 2026: floor debate, Senate
  • March 26, 2026: floor debate, Senate
  • April 15, 2026, 1:45 PM: public hearing, House Commerce and Consumer Affairs, GP 229
  • April 22, 2026, 10:00 AM: subcommittee work session, House Commerce and Consumer Affairs, GP 229
  • April 28, 2026, 10:00 AM: subcommittee work session, House Commerce and Consumer Affairs, GP 229
  • April 29, 2026, 10:00 AM: executive session, House Commerce and Consumer Affairs, GP 229
  • May 14, 2026: floor debate, House

Votes

  • March 26, 2026, Senate: Ought to Pass with Amendment — yeas 24, nays 0, passed
  • May 14, 2026, House: Inexpedient to Legislate — voice vote, passed

The Docket

  • January 29, 2026: Introduced 01/29/2026 and Referred to Health and Human Services
  • February 18, 2026: Hearing: 02/18/2026, Room 100, SH, 09:45 am
  • March 12, 2026: Committee Report: Ought to Pass with Amendment # 2026-1047s, 03/12/2026; Vote 5-0; CC
  • March 12, 2026: SB 665 was Removed from the Consent Calendar; 03/12/2026
  • March 12, 2026: Special Order to 03/26/2026, Without Objection, MA; 03/12/2026
  • March 26, 2026: Committee Report: Ought to Pass with Amendment # 2026-1047s, 03/26/2026, Vote 5-0
  • March 26, 2026: Committee Amendment # 2026-1047s, AA, VV; 03/26/2026
  • March 26, 2026: Sen. Ricciardi Floor Amendment # 2026-1239s, AA, VV; 03/26/2026
  • March 26, 2026: Sen. Rosenwald Floor Amendment # 2026-1129s, AA, VV; 03/26/2026
  • March 26, 2026: Ought to Pass with Amendments #2026-1047s, and #2026-1239s and #2026-1129s, RC 24Y-0N, MA; OT3rdg; 03/26/2026
  • March 26, 2026: Introduced (in recess of) 03/26/2026 and referred to Commerce and Consumer Affairs
  • April 15, 2026: Public Hearing: 04/15/2026 01:45 pm GP 229
  • April 22, 2026: Subcommittee Work Session: 04/22/2026 10:00 am GP 229
  • April 28, 2026: Subcommittee Work Session: 04/28/2026 10:00 am GP 229
  • April 29, 2026: Executive Session: 04/29/2026 10:00 am GP 229
  • April 29, 2026: Majority Committee Report: Inexpedient to Legislate 04/29/2026 (Vote 13-2; RC)
  • May 1, 2026: Minority Committee Report: Ought to Pass with Amendment # 2026-1758h
  • May 14, 2026: Inexpedient to Legislate: MA VV 05/14/2026

Laws It Would Change

Related Bills

From the General Court